SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

RUZZA, Chiara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.571
AS - Asia 2.273
EU - Europa 1.477
SA - Sud America 445
AF - Africa 47
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.815
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.485
SG - Singapore 996
CN - Cina 603
IT - Italia 400
BR - Brasile 363
DE - Germania 228
HK - Hong Kong 200
PL - Polonia 188
VN - Vietnam 177
GB - Regno Unito 146
UA - Ucraina 129
TR - Turchia 94
FI - Finlandia 90
RU - Federazione Russa 74
ID - Indonesia 49
SE - Svezia 48
CA - Canada 47
FR - Francia 43
AR - Argentina 35
IN - India 32
MX - Messico 29
BD - Bangladesh 27
JP - Giappone 23
ZA - Sudafrica 23
NL - Olanda 22
BE - Belgio 17
ES - Italia 17
IE - Irlanda 17
EC - Ecuador 15
AT - Austria 13
IQ - Iraq 13
LT - Lituania 13
CZ - Repubblica Ceca 12
VE - Venezuela 9
PK - Pakistan 8
AE - Emirati Arabi Uniti 7
KE - Kenya 7
UZ - Uzbekistan 7
PE - Perù 6
CO - Colombia 5
SA - Arabia Saudita 5
KZ - Kazakistan 4
TN - Tunisia 4
UY - Uruguay 4
BG - Bulgaria 3
CH - Svizzera 3
CL - Cile 3
DK - Danimarca 3
IL - Israele 3
KR - Corea 3
KW - Kuwait 3
MA - Marocco 3
NP - Nepal 3
RO - Romania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AZ - Azerbaigian 2
BB - Barbados 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GY - Guiana 2
IR - Iran 2
JO - Giordania 2
KG - Kirghizistan 2
LV - Lettonia 2
NG - Nigeria 2
NI - Nicaragua 2
NO - Norvegia 2
PH - Filippine 2
PY - Paraguay 2
AL - Albania 1
AO - Angola 1
BO - Bolivia 1
DM - Dominica 1
EG - Egitto 1
ET - Etiopia 1
GE - Georgia 1
JM - Giamaica 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
ML - Mali 1
MY - Malesia 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TW - Taiwan 1
ZW - Zimbabwe 1
Totale 8.815
Salva come PNG Salva come JPEG
Città #
Ashburn 650
Singapore 551
Fairfield 498
Woodbridge 401
Santa Clara 256
Beijing 240
Houston 237
Seattle 218
Hong Kong 195
Cambridge 194
Ann Arbor 183
Wilmington 183
Warsaw 182
Chandler 161
Jacksonville 153
Ferrara 148
Los Angeles 100
Munich 87
New York 86
Ho Chi Minh City 67
Shanghai 62
Dallas 61
Princeton 57
Milan 56
Izmir 53
Nanjing 44
Jakarta 38
Bologna 37
London 36
São Paulo 35
San Diego 32
Dearborn 31
Hanoi 31
Helsinki 31
Chicago 30
Turku 28
Boardman 27
Frankfurt am Main 22
Atlanta 21
Brooklyn 20
Tokyo 20
Mexico City 19
Montreal 17
Belo Horizonte 16
Brussels 16
Denver 16
Dublin 16
Falkenstein 16
Addison 15
Orem 15
Johannesburg 14
Moscow 14
Nanchang 14
Buffalo 13
Hefei 13
Phoenix 13
Shenyang 13
Tianjin 13
Toronto 13
Assago 12
Falls Church 12
Norwalk 12
Rio de Janeiro 12
Stockholm 12
Padova 11
Brasília 10
Chennai 10
Da Nang 10
Guangzhou 10
Manchester 10
Bremen 9
San Francisco 9
Nuremberg 8
Poplar 8
Porto Alegre 8
Redwood City 8
The Dalles 8
Vienna 8
Washington 8
Boston 7
Changsha 7
Guayaquil 7
Hebei 7
Nairobi 7
Olomouc 7
Bari 6
Bexley 6
Council Bluffs 6
Dhaka 6
Ferrara di Monte Baldo 6
Jiaxing 6
Mountain View 6
Mumbai 6
Roubaix 6
Tashkent 6
Ankara 5
Auburn Hills 5
Augusta 5
Biên Hòa 5
Charlotte 5
Totale 6.150
Salva come PNG Salva come JPEG
Nome #
Pharmacological and neurobiological studies on Neuropeptide S and its receptor 233
Behavioural phenotypic characterization of CD-1 mice lacking the neuropeptide S receptor 220
Neuropeptide S reduces mouse aggressiveness in the resident/intruder test through selective activation of the neuropeptide S receptor 208
Anxiolytic- and panicolytic-like effects of Neuropeptide S in the mouse elevated T-maze. 206
[D-Pen(p-tBuBzl)5]NPS, a novel ligand for the neuropeptide S receptor: structure activity and pharmacological studies 205
Biased Agonism at Nociceptin/Orphanin FQ Receptors: A Structure Activity Study on N/OFQ(1-13)-NH2 199
Modulation of the NOP receptor signaling affects resilience to acute stress 196
[(t)Bu-d-Gly(5)]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies 190
Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic- versus antidepressant-like effects of nociceptin/orphanin FQ receptor ligands 190
Pharmacological characterization of tachykinin tetrabranched derivatives 190
Synthesis and biological activity of human neuropeptide S analogues modified in position 2 189
Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt(1)]N/OFQ(1-13) 188
Further studies at neuropeptide S position 5: Discovery of novel neuropeptide S receptor antagonists 178
In vitro and in vivo pharmacological characterization of Pronetupitant, a prodrug of the neurokinin 1 receptor antagonist Netupitant 176
Antinociceptive action of NOP and opioid receptor agonists in the mouse orofacial formalin test 175
Peptide welding technology – A simple strategy for generating innovative ligands for G protein coupled receptors 175
Neuropeptide S receptor ligands: a patent review (2005-2016) 170
Structure-activity study at positions 3 and 4 of human neuropeptide S. 168
In vitro functional characterization of novel nociceptin/orphanin FQ receptor agonists in recombinant and native preparations 167
Neuropeptide S is a stimulatory anxiolytic agent: A behavioural study in mice 167
Synthesis and Biological Activity of Human Neuropeptide S Analogues Modified in Position 5: Identification of Potent and Pure Neuropeptide S Receptor Antagonists 164
Pharmacological profile of the neuropeptide S receptor: Dynamic mass redistribution studies 164
In vitro and in vivo pharmacological characterization of the novel neuropeptide S receptor ligands QA1 and PI1 158
Synthesis and separation of the enantiomers of the neuropeptide S receptor antagonist (9R/S)-3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide (SHA 68). 155
Tetrabranched Hetero-Conjugated Peptides as Bifunctional Agonists of the NOP and Mu Opioid Receptors 155
In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [D-Cys(tBu)5]neuropeptide S 155
In vitro and in vivo pharmacological characterization of nociceptin/orphanin FQ tetrabranched derivatives 152
Pharmacological characterization of cebranopadol a novel analgesic acting as mixed nociceptin/orphanin FQ and opioid receptor agonist 148
Spinal antinociceptive effects of the novel NOP receptor agonist PWT2-nociceptin/orphanin FQ in mice and monkeys 141
NOP agonist action of cebranopadol counteracts its liability to promote physical dependence 135
Structure-Activity Relationship Studies on Oxazolo[3,4- a]pyrazine Derivatives Leading to the Discovery of a Novel Neuropeptide S Receptor Antagonist with Potent in Vivo Activity 126
NOP agonists prevent the antidepressant-like effects of nortriptyline and fluoxetine but not R-ketamine 125
Pharmacology of Kappa Opioid Receptors: Novel Assays and Ligands 124
The concise guide to pharmacology 2021/22: G protein-coupled receptors 119
Novel Mixed NOP/Opioid Receptor Peptide Agonists 117
Synthesis and Pharmacological Evaluation of Hybrids Targeting Opioid and Neurokinin Receptors 116
Dopamine D1 and D2 receptors mediate neuropeptide S-induced antinociception in the mouse formalin test 113
null 110
Functional Selectivity Does Not Predict Antinociceptive/Locomotor Impairing Potencies of NOP Receptor Agonists 110
Effects of non-peptide nociceptin/orphanin FQ receptor ligands on methylphenidate-induced hyperactivity in mice: Implications for bipolar disorders 109
In vitro and in vivo pharmacological characterization of a neuropeptide S tetrabranched derivative 107
null 105
Detailed in vitro pharmacological characterization of the clinically viable nociceptin/orphanin FQ peptide receptor antagonist BTRX-246040 99
NOP Ligands for the Treatment of Anxiety and Mood Disorders 97
Biased versus Partial Agonism in the Search for Safer Opioid Analgesics 94
Lack of Direct Effects of Neurotrophic Factors in an In Vitro Model of Neuroinflammation 92
Blockade of NOP receptor modulates anxiety-related behaviors in mice exposed to inescapable stress 92
Blockade of nociceptin/orphanin FQ signaling facilitates an active copying strategy due to acute and repeated stressful stimuli in mice 91
Nociceptin/orphanin FQ receptor agonists increase aggressiveness in the mouse resident-intruder test 89
Pharmacological characterization of naloxegol: In vitro and in vivo studies 88
null 87
Preclinical effects of cannabidiol in an experimental model of migraine 86
Further studies on the pharmacological profile of the neuropeptide S receptor antagonist SHA 68. 85
The NOP antagonist BTRX-246040 increases stress resilience in mice without affecting adult neurogenesis in the hippocampus 83
null 77
Activation of NOP receptor increases vulnerability to stress: role of glucocorticoids and CRF signaling 76
Highly differentiated T cells link systemic and vascular inflammation in a mouse model of recurrent psoriasis 73
Blockade of nociceptin/orphanin FQ receptor signaling reverses LPS-induced depressive-like behavior in mice 73
In vitro pharmacological characterization of growth hormone secretagogue receptor ligands using the dynamic mass redistribution and calcium mobilization assays 72
In vitro pharmacological characterization of standard and new lysophosphatidic acid receptor antagonists using dynamic mass redistribution assay 72
The concise guide to pharmacology 2019/20: G protein-coupled receptors 69
Synthesis, Biological Activity and Molecular Docking of Chimeric Peptides Targeting Opioid and NOP Receptors 67
Effects of Stress Exposure to Pain Perception in Pre-Clinical Studies: Focus on the Nociceptin/Orphanin FQ-NOP Receptor System 66
Racemic synthesis and solid phase peptide synthesis application of the chimeric valine/leucine derivative 2-amino-3,3,4-trimethyl-pentanoic acid 65
Pharmacology, physiology and genetics of the neuropeptide s system 61
Identification of isoxazole-based TRPA1 inhibitors with analgesic effects in vivo 58
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors 55
In vitro pharmacological evaluation of the novel NOP receptor partial agonist sunobinop 53
Activation of peripheral NOP receptors reduces periorbital mechanical allodynia evoked by CGRP in mice 43
null 42
Nociceptin/orphanin FQ receptor system blockade as an innovative strategy for increasing resilience to stress 42
Sex differences in response to NLRP3 inflammasome blockage in a mouse migraine model: A genetic and pharmacological study 37
Nociceptin/OrphaninFQ Receptor Modulates the Maturation of Adult-Born Neurons in the Mouse Dentate Gyrus Under Physiological Conditions and in a Chronic Stress Model 31
An Insight into Neuronal Processing of Ghrelin: Effects of a Bioactive Ghrelin Derivative on Proteolytic Pathways and Mitophagy 29
The concise guide to pharmacology 2017/18: Overview 23
Synthesis and Pharmacological Characterization of Nociceptin/Orphanin FQ Dimeric Ligands 20
Totale 8.985
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.640
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 715
Totale 47.355
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021491 0 0 0 0 0 81 66 78 41 102 74 49
2021/2022524 33 35 28 39 37 38 27 41 24 52 35 135
2022/2023455 58 42 23 48 58 44 39 37 50 5 27 24
2023/2024427 32 47 25 14 26 78 22 39 4 21 14 105
2024/20251.682 43 43 153 73 191 177 16 73 293 169 238 213
2025/20262.943 562 274 407 619 806 275 0 0 0 0 0 0
Totale 8.985